Individualizing Antihyperglycemic Agents in Type 2 Diabetes

Duration

15 mins

Profession

Physician

# of Credits

0.25

Accreditation

Mainpro+

Expiry Date

2020-10-09

In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies.

​This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ Credit(s). Cert+ Program ID#: 190712

N/A

Peter Lin, MD, CCFP
David C.W. Lau, MD, PhD, FRCPC
Thomas Round, MBBS, BSc, DRCOG, MRCGP
David Strain, MB, ChB, BSc (Hons) MD, FRCP
Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC
Robyn L. Houlden, MD, FRCPC
John Axler, MD, CCFP, FCFP
Deanna Telner, MD, MEd, CCFP, FCFP
Jeffrey Habert, MD, CCFP, FCFP

N/A



Related Courses